Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The sterol-C4-methyl oxidase pseudogene (SC4MOP/DESP4P1) is a genomic sequence similar to the functional sterol-C4-methyl oxidase gene but contains disabling mutations that prevent it from producing a functional enzyme. Pseudogenes like SC4MOP may produce RNA transcripts that can influence cellular biology by regulating the expression of their cognate genes through mechanisms such as competing for microRNA binding (acting as "microRNA decoys") or generating regulatory small RNAs. However, SC4MOP itself does not encode a functional enzyme and is not a drug, biomarker, or therapeutic target[5][1][3]. There is no documentation of disease association, mechanism of drug action, or safety concerns related to SC4MOP, and its only known biological relevance comes from the general role of pseudogene transcripts in gene regulation[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol-C4-methyl oxidase pseudogene (SC4MOP).